(S)-2-((S)-2-((S)-2-(4-aminobutanamido)-3-(5-hydroxy-1H-indol-3-yl)propanamido)-3-(naphthalen-1-yl)propanamido)-6-guanidinohexanamide

ID: ALA4865344

PubChem CID: 164620528

Max Phase: Preclinical

Molecular Formula: C35H45N9O5

Molecular Weight: 671.80

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1cccc2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O

Standard InChI:  InChI=1S/C35H45N9O5/c36-15-6-12-31(46)42-29(18-23-20-41-27-14-13-24(45)19-26(23)27)33(48)44-30(17-22-9-5-8-21-7-1-2-10-25(21)22)34(49)43-28(32(37)47)11-3-4-16-40-35(38)39/h1-2,5,7-10,13-14,19-20,28-30,41,45H,3-4,6,11-12,15-18,36H2,(H2,37,47)(H,42,46)(H,43,49)(H,44,48)(H4,38,39,40)/t28-,29-,30-/m0/s1

Standard InChI Key:  UWECIGAYVDGPCF-DTXPUJKBSA-N

Molfile:  

 
     RDKit          2D

 49 52  0  0  0  0  0  0  0  0999 V2000
   19.8299  -26.4225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1221  -26.0141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1219  -25.1969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4141  -24.7884    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8295  -24.7881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5373  -25.1965    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.2449  -24.7878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9527  -25.1962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6604  -24.7874    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.9529  -26.0134    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.8293  -23.9709    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.7065  -25.1972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9987  -24.7888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7067  -26.0144    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.2911  -25.1975    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5833  -24.7891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8757  -25.1979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5831  -23.9719    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.9985  -23.9716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7061  -23.5628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4549  -23.9004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0016  -23.2930    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.7935  -22.7555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5944  -22.5872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8475  -21.8109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3008  -21.2023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4977  -21.3752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2483  -22.1512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2447  -23.9706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9524  -23.5618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9522  -22.7446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6598  -22.3358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6596  -21.5187    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.3672  -21.1099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3670  -20.2927    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.0750  -21.5183    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.1679  -24.7895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4602  -25.1982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9491  -20.7695    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.7524  -24.7898    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.2402  -27.2362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2374  -26.4148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5298  -26.0101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5316  -27.6450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8271  -27.2381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1246  -27.6446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1253  -28.4580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8345  -28.8630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5341  -28.4541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
  5 11  2  0
  4 12  1  0
 12 13  1  0
 12 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 13 19  1  1
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 24  1  0
 23 20  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
  7 29  1  1
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  2  0
 34 36  1  0
 17 37  1  0
 37 38  1  0
 27 39  1  0
 38 40  1  0
  1 45  2  0
 44 41  2  0
 41 42  1  0
 42 43  2  0
 43  1  1  0
 44 45  1  0
 45 46  1  0
 46 47  2  0
 47 48  1  0
 48 49  2  0
 49 44  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4865344

    ---

Associated Targets(Human)

EPHA4 Tchem Ephrin type-A receptor 4 (2022 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 671.80Molecular Weight (Monoisotopic): 671.3544AlogP: 1.14#Rotatable Bonds: 18
Polar Surface Area: 254.33Molecular Species: BASEHBA: 7HBD: 10
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 13#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.55CX Basic pKa: 11.83CX LogP: 0.16CX LogD: -4.01
Aromatic Rings: 4Heavy Atoms: 49QED Weighted: 0.04Np Likeness Score: 0.11

References

1. Baggio C, Kulinich A, Dennys CN, Rodrigo R, Meyer K, Ethell I, Pellecchia M..  (2021)  NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands.,  64  (15.0): [PMID:34293864] [10.1021/acs.jmedchem.1c00608]

Source